The next-generation CaviWipes 2.0 builds on a decades-long reputation of being trusted by clinicians with strong efficacy claims paramount during times of public health crisis and qualifies for all levels of the EPA's rigorous Emerging Viral Pathogen Claim, including enveloped viruses, small non-enveloped viruses, and large non-enveloped viruses. 2-minute universal contact time against all 60 listed pathogens including SARS-CoV-2, Norovirus.